Newsroom

Sorted by: Latest

-

Oklo, Centrus Sign Letter of Intent to Purchase Nuclear Fuel for Aurora Powerhouse Deployment in Southern Ohio

PIKE COUNTY, Ohio--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, and Centrus Energy Corp. (NYSE: LEU) (“Centrus”), a uranium enrichment and nuclear fuel services provider, announced today a Letter of Intent under which Centrus agrees to supply enough domestic high-assay low-enriched uranium (HALEU) to power up to five Aurora powerhouses for multiple years, with deliveries to Oklo scheduled to begin in 2029. Centrus will supply HALEU from its American...
-

MarketAxess Introduces TraX Tape, Delivering an Enriched View of Bond Market Activity

LONDON--(BUSINESS WIRE)--MarketAxess Holdings Inc. (Nasdaq: MKTX) today announced the launch of TraX® Tape, a data solution that delivers a clean, consolidated view of bond market activity, enriched with additional context and real-time insights. The launch comes as UK and EU transparency reforms increase the availability of bond trading data while adding complexity to how that data is reported and interpreted. TraX Tape addresses these challenges by providing a single, standardised feed that c...
-

Veteran Investor and Widely Followed Market Analyst Shah Gilani Calls VENU Stock “Significantly Undervalued”

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today released a recorded investor Q&A between Founder, Chairman, and CEO J.W. Roth and veteran investor, retired hedge fund manager, and widely followed market analyst Shah Gilani, Founder and Chief Investment Strategist at ANNSR Market Analytics. You can watch the interview here. In the conversatio...
-

MedTech Innovator Welcomes Dr. Jeffrey Shuren as Advisor

LOS ANGELES--(BUSINESS WIRE)--MedTech Innovator welcomes former FDA CDRH Director Dr. Jeffrey Shuren as Advisor on regulatory and market-access strategy....
-

Deluxe to Acquire Celero Commerce, Accelerating Transformation Toward Payments and Data Solutions Scale

MINNEAPOLIS--(BUSINESS WIRE)--Deluxe (NYSE: DLX), a trusted payments and data company, today announced that it has entered into a definitive agreement to acquire Celero Commerce (“Celero”), a financial technology company focused on optimized payment solutions for small to mid-sized businesses and strategic partners, for $625 million, plus payment of certain seller transaction expenses and other adjustments. Celero is an industry-leading integrated payment processing partner offering high-tech,...
-

New Boardwalk Built by Promega Opens Public Access to Nevin Springs Wetland Along Capital City State Trail in Fitchburg

MADISON, Wis.--(BUSINESS WIRE)--Promega builds $1 million 720-foot boardwalk providing public access to Nevin Springs wetland along Capital City State Trail in Fitchburg, WI....
-

Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced it is advancing zelicapavir into a registrational Phase 2b/3 clinical trial in adults at high risk of severe outcomes from RSV infection after a successful End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA). The Phase 2b portion of the trial will confi...
-

Enhanced Closes Initial Tranche of $50 Million Financing

NEW YORK--(BUSINESS WIRE)--Enhanced Closes Initial Tranche of $50 Million Financing...
-

Cognitiv’s Full-Funnel CTV Drives Competitive Edge for Fanatics Sportsbook

NEW YORK--(BUSINESS WIRE)--Cognitiv, the leading advanced performance partner powered by deep learning, today announced its full-funnel CTV solution has delivered a 19% lift in customer lifetime value for Fanatics Sportsbook. Built to drive outcomes across awareness, consideration, and performance, Cognitiv CTV combines deep learning-powered audience intelligence, advertiser-specific algorithms, and premium streaming inventory to help brands reach high-value audiences across CTV at scale. “We a...
-

Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced topline results today from its Phase 3 TRIDENT trial, which evaluated the initiation of Tumor Treating Fields (TTFields) therapy for newly diagnosed glioblastoma (GBM) at the start of chemoradiation (Early Start Arm) compared to initiating TTFields therapy during the subsequent maintenance phase of treatment (Maintenance Start Arm). The trial did not demonstrate a statistically significant improvement in the primary endpoint...